ARCHIVES

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

Four NCAB Appointments Announced, Including Durant, Fisher; White House Delays On Others

April 4, 1986

Hopkins Begins Review Of All Studies After OHRP Lifts Research Suspension.

July 27, 2001

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

November 14, 2008

Fraumeni Appointed field Studies Chief

January 18, 1980

Decade-Long Cover-up?

January 6, 1995